ModivCare Inc. Faces Class Action Lawsuit
In recent news, ModivCare Inc. is under scrutiny as a class action securities lawsuit has been initiated against the company. The law firm, Levi & Korsinsky, LLP, is reaching out to investors of ModivCare to represent their interests during this legal challenge. This lawsuit is a significant moment for stakeholders as it addresses crucial financial matters connected to the company.
Understanding the Class Action
This class action was filed to recover losses for investors who have potentially been impacted by allegations of securities fraud. The timeline for claims covers events that occurred between November 3, 2022, and September 15, 2024. This period is crucial for anyone who invested in ModivCare during these dates.
Key Definitions
A class action lawsuit is a legal action filed by a group of individuals who share a common interest—in this case, investors in ModivCare. They claim that misleading information and false statements were provided by the company regarding its financial health and business operations.
The Allegations
The lawsuit alleges that ModivCare's management made significant misrepresentations about their contracts, especially in their Non-Emergency Medical Transportation (NEMT) segment. The claim states that these false claims resulted in a significant decline in the company's free cash flow, raising concerns over liquidity and ultimately leading to adjustments that negatively affected the company’s earnings before interest, taxes, depreciation, and amortization (EBITDA).
Next Steps for Investors
If you believe you qualify as a class member, it is essential to act quickly. The deadline to be designated as a lead plaintiff in this lawsuit is March 31, 2025. However, it’s important to remember that you do not need to take on this role to be eligible for any recovery that may arise from this lawsuit.
Potential No-Cost Compensation
Investors who are part of this class action may be entitled to compensation without any out-of-pocket costs or legal fees. This is a crucial aspect of the litigation, as it allows shareholders to seek justice without financial risks.
Why Choose Levi & Korsinsky?
Levi & Korsinsky has established a reputation for being a powerful ally in securities litigation over two decades. They have successfully recovered hundreds of millions for investors with a strong track record in handling complex financial cases. With a dedicated team of over 70 professionals, they are well-equipped to navigate the intricacies of securities law.
Contact Information
ModivCare investors are encouraged to reach out to Joseph E. Levi, Esq., at Levi & Korsinsky for more information. You can contact him via email at jlevi@levikorsinsky.com or by phone at (212) 363-7500.
Frequently Asked Questions
What is the class action lawsuit about?
The lawsuit involves allegations of securities fraud by ModivCare Inc., claiming that misleading information led to financial losses for investors.
Who can file a claim?
Any investor who purchased ModivCare shares between November 3, 2022, and September 15, 2024, may be eligible to file a claim.
What are the potential costs to file a claim?
There are no costs or fees for class members to participate in the lawsuit.
What does being a lead plaintiff entail?
A lead plaintiff would take an active role in the lawsuit process but is not necessary for recovery of losses.
How can I contact Levi & Korsinsky for more information?
You can reach out to Joseph E. Levi via email at jlevi@levikorsinsky.com or by phone at (212) 363-7500.
